A Stanford-led team has replaced toxic pre-transplant chemotherapy with a targeted antibody, allowing children with Fanconi ...

Key opportunities in the U.S. regenerative medicine market include the rising adoption of stem cell technology and a strong ...

Florida's new stem cell law, why out-of-state universities keep setting up satellite campuses in the area, a 3D-printed ...

Innovations Stem Cell Center, recently named the top U.S. stem-cell therapy provider by Life Sciences Review, offers patients a safe, standardized, and affordable alternative to unregulated overseas ...

Hippel indicated that overall Q2 organic growth is anticipated to be consistent with Q1, with continued strength in pharma, renewed growth in China, a rebound in spatial biology, and gradual ...

Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the company will present updated safety and efficacy ...